AFW Stock Chart & Stats
€135.05
€0.00(0.00%)
At close: 4:00 PM EDT
€135.05
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€105.40 - €166.60
Previous CloseN/A
Volume0.00
Average Volume (3M)4.00
Market Cap
€9.70B
Enterprise Value€11.08K
Total Cash (Recent Filing)€1.10B
Total Debt (Recent Filing)€120.84M
Price to Earnings (P/E)27.6
Beta1.03
Next Earnings
Oct 28, 2026EPS Estimate
2.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.76
Shares Outstanding71,039,850
10 Day Avg. Volume8
30 Day Avg. Volume4
Financial Highlights & Ratios
PEG Ratio51.77
Price to Book (P/B)2.80
Price to Sales (P/S)2.81
P/FCF Ratio23.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€183.09Price Target Upside35.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)9.68
Revenue Forecast (FY)€3.57B
Bulls Say, Bears Say
Bulls Say
Patent ProtectionThe favorable infringement ruling strengthens Align’s intellectual-property moat in a key market. Injunctions, damages, and ongoing actions may deter imitation, protect innovation economics, and support differentiation in digital orthodontics.
Digital Ecosystem AdoptionExpanding iTero adoption and scan activity deepen Align’s integrated digital workflow with dental providers. A larger installed base can support recurring software and services demand while feeding Invisalign case submissions and strengthening ecosystem retention.
Balance Sheet And Cash GenerationMinimal leverage and strong cash conversion give Align resilience to invest through industry cycles, fund innovation, and execute capital returns. Financial flexibility also reduces dependence on external financing as the company addresses operating and regulatory challenges.
Bears Say
Systems Revenue WeaknessThe deliberate move toward lower-priced scanners, leases, and rentals reduces upfront revenue and may defer profitability. Continued weakness in Systems and Services could offset Clear Aligner growth and make overall expansion more dependent on case volumes.
Margin Recovery RiskProfitability remains well below prior-cycle peaks, indicating that operating leverage has not fully returned. Restructuring and accelerated-depreciation charges add near-term pressure, while sustained margin recovery depends on execution, mix, and expense discipline.
UK VAT LiabilityThe adverse VAT ruling creates a direct financial obligation and may raise the tax burden on applicable UK transactions. Although Align intends to appeal, the ruling introduces lasting regulatory uncertainty and potential pricing or demand pressure in that market.
AFW FAQ
What was Align Tech’s price range in the past 12 months?
Align Tech lowest stock price was €105.40 and its highest was €166.60 in the past 12 months.
What is Align Tech’s market cap?
Align Tech’s market cap is €9.70B.
When is Align Tech’s upcoming earnings report date?
Align Tech’s upcoming earnings report date is Oct 28, 2026 which is in 61 days.
How were Align Tech’s earnings last quarter?
Align Tech released its earnings results on Jul 29, 2026. The company reported €2.263 earnings per share for the quarter, beating the consensus estimate of €2.243 by €0.021.
Is Align Tech overvalued?
According to Wall Street analysts Align Tech’s price is currently Undervalued.
Does Align Tech pay dividends?
Align Tech does not currently pay dividends.
What is Align Tech’s EPS estimate?
Align Tech’s EPS estimate is 2.4.
How many shares outstanding does Align Tech have?
Align Tech has 71,039,850 shares outstanding.
What happened to Align Tech’s price movement after its last earnings report?
Align Tech reported an EPS of €2.263 in its last earnings report, beating expectations of €2.243. Following the earnings report the stock price went down -0.43%.
Which hedge fund is a major shareholder of Align Tech?
Currently, no hedge funds are holding shares in DE:AFW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Align Tech Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€183.09 (35.58% Upside)
€183.09 (35.58% Upside)
Blogger Sentiment
Neutral
DE:AFW Sentiment 50%
Sector Average 61%
Sector Average 61%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-17.39%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.19%
Trailing 12-Months
Company Description
Align Tech
Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.
AFW Company Deck
AFW Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple clear wins — record revenues, record Clear Aligner volumes, non-GAAP margin expansion, strong cash balance and aggressive buybacks, and robust scanner adoption and digital workflow usage. Offsetting these positives are notable near-term headwinds: a double-digit decline in Systems & Services revenue driven by a strategic shift to lower-priced scanner offerings and leases, elevated operating expenses and one-time charges that pressure GAAP margins, a material U.K. VAT liability (~$37.5M), and FX-related margin/EPS impacts. Management framed the scanner mix shift as intentional, emphasizing long-term platform growth even as it depresses near-term reported revenue and upfront profitability. Given the number and magnitude of substantive positive operational and financial metrics and management’s constructive long-term positioning despite identifiable near-term challenges, the overall tone of the call is cautiously optimistic.View all DE:AFW earnings summariesAFW Revenue Breakdown
80.43% Clear Aligner
19.57% Systems and Services

AFW Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€183.09
▲(35.58% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Smith & Nephew Snats
―
Ufp Technologies
―
Zimmer Biomet Holdings
―
Globus Medical
―
Glaukos
―










